Filters close
access_time Embargo lifts in 2 days
Embargo will expire: 17-Apr-2024 10:00 AM EDT Released to reporters: 15-Apr-2024 12:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 17-Apr-2024 10:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Andrew Smith, MD, PhD, named chair of Diagnostic Imaging at St. Jude Children’s Research Hospital
Released: 15-Apr-2024 11:00 AM EDT
Andrew Smith, MD, PhD, named chair of Diagnostic Imaging at St. Jude Children’s Research Hospital
St. Jude Children's Research Hospital

Smith is a nationally recognized academic radiologist with expertise in body and oncologic imaging, clinical trials and imaging research and the application of artificial intelligence (AI) in imaging and medicine.

Released: 15-Apr-2024 10:05 AM EDT
Pesquisadores da Mayo Clinic criaram uma nova classe de algoritmos com IA para melhorar a pesquisa e os tratamentos contra o câncer
Mayo Clinic

Pesquisadores da Mayo Clinic criaram recentemente uma nova classe de algoritmos com inteligência artificial (IA) chamada IA orientada por hipóteses; se trata de um caminho alternativo dos modelos tradicionais de IA que aprendem apenas com dados.

Released: 15-Apr-2024 10:05 AM EDT
Investigadores de Mayo Clinic han creado una nueva clase de algoritmos impulsados por IA para mejorar la investigación y los tratamientos contra el cáncer
Mayo Clinic

Investigadores de Mayo Clinic crearon recientemente una nueva clase de algoritmos con inteligencia artificial (IA) llamada IA impulsada por hipótesis; se trata de una vía alternativa a los modelos tradicionales de IA que aprenden solo con datos.

Newswise: NCCN Foundation Announces Recipients for 2024 Young Investigator Awards Honoring Future Leaders of Cancer Research
Released: 15-Apr-2024 8:30 AM EDT
NCCN Foundation Announces Recipients for 2024 Young Investigator Awards Honoring Future Leaders of Cancer Research
National Comprehensive Cancer Network® (NCCN®)

The National Comprehensive Cancer Network (NCCN) and the NCCN Foundation announce five winners for the 2024 NCCN Foundation Young Investigator Awards (YIA).

Newswise: FDA’s ODAC Rules Unanimously on a Faster Way to Approve Multiple Myeloma Therapies
Released: 12-Apr-2024 5:05 PM EDT
FDA’s ODAC Rules Unanimously on a Faster Way to Approve Multiple Myeloma Therapies
Sylvester Comprehensive Cancer Center

An FDA advisory committee (ODAC) voted 12-0 today in favor of a major shift in how the agency evaluates new treatments for multiple myeloma. If approved by the FDA, the result will be faster approval of new treatments for multiple myeloma.

Newswise: Utah Governor’s Medal Given to Neli Ulrich, PhD, MS, for Outstanding Research and Leadership
Released: 12-Apr-2024 4:05 PM EDT
Utah Governor’s Medal Given to Neli Ulrich, PhD, MS, for Outstanding Research and Leadership
Huntsman Cancer Institute at the University of Utah

Neli Ulrich joins a select group of recipients recognized for their impactful work in science and technology in Utah.

access_time Embargo lifts in 2 days
Embargo will expire: 16-Apr-2024 4:00 PM EDT Released to reporters: 12-Apr-2024 3:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 16-Apr-2024 4:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Scott Oakes named Vice Dean for Clinical Science Research
Released: 12-Apr-2024 12:05 PM EDT
Scott Oakes named Vice Dean for Clinical Science Research
University of Chicago Medical Center

The Vice Dean for Clinical Science Research is a new leadership role accountable for successfully implementing the research strategic plan as it pertains to clinical science within the overall BSD/PSOM research mission.

Newswise: Seth Himelhoch named Chair of the Department of Psychiatry and Behavioral Neuroscience at the University of Chicago
Released: 12-Apr-2024 12:05 PM EDT
Seth Himelhoch named Chair of the Department of Psychiatry and Behavioral Neuroscience at the University of Chicago
University of Chicago Medical Center

Himelhoch comes to UChicago from the University of Kentucky, where his public health research has focused on interventions for those with HIV and substance use disorders and cancer control.

Released: 12-Apr-2024 12:00 PM EDT
MD Anderson Research Highlights for April 12, 2024
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.

   
Newswise: NUS scientists uncover a missing link between poor diet and higher cancer risk
Released: 11-Apr-2024 10:05 PM EDT
NUS scientists uncover a missing link between poor diet and higher cancer risk
National University of Singapore (NUS)

A research team from the National University of Singapore (NUS) has unearthed new findings which may help explain the connection between cancer risk and poor diet, as well as common diseases like diabetes, which arise from poor diet.

access_time Embargo lifts in 2 days
Embargo will expire: 11-Apr-2024 3:05 PM EDT Released to reporters: 11-Apr-2024 3:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 11-Apr-2024 3:05 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Smart nanoprobe illuminates prostate cancer cells
Released: 11-Apr-2024 1:05 PM EDT
Smart nanoprobe illuminates prostate cancer cells
National Institute of Biomedical Imaging and Bioengineering

NIBIB-supported researchers have developed a smart nanoprobe designed to infiltrate prostate tumors and send back a signal using an optical imaging technique known as Raman spectroscopy.

   
Newswise: Helping diverse populations with the psychosocial impacts of cancer
Released: 11-Apr-2024 1:05 PM EDT
Helping diverse populations with the psychosocial impacts of cancer
University of Delaware

A University of Delaware professor is testing interventions that address the psychosocial needs of African American patients with cancer and their families, with the goal of boosting communication skills and decreasing anxiety and depression for children whose parents have cancer.

Newswise: Researchers Identify New Genetic Risk Factors for Persistent HPV Infections
Released: 11-Apr-2024 9:05 AM EDT
Researchers Identify New Genetic Risk Factors for Persistent HPV Infections
University of Maryland School of Medicine

Human papillomavirus (HPV) is the second most common cancer-causing virus, accounting for 690,000 cervical and other cancers each year worldwide.

Newswise: NCCN 2024 Annual Conference Shares Cancer Care Updates for Practical, Immediate Use in Practice
Released: 11-Apr-2024 8:30 AM EDT
NCCN 2024 Annual Conference Shares Cancer Care Updates for Practical, Immediate Use in Practice
National Comprehensive Cancer Network® (NCCN®)

More than 1,700 oncology professionals attended National Comprehensive Cancer Network meeting in Orlando and online, featuring clinical and administrative updates for improving cancer care worldwide, plenary sessions on Lynch syndrome and drug shortages, plus nearly 200 poster abstracts with new research.

Newswise: Next-gen lab chip transforms cancer detection: triple-threat cell sorting unveiled
Released: 11-Apr-2024 8:05 AM EDT
Next-gen lab chip transforms cancer detection: triple-threat cell sorting unveiled
Chinese Academy of Sciences

Researchers have unveiled a microfluidic device that significantly improves the separation of tumor cells and clusters from malignant effusions. This novel technology promises to advance the diagnosis and treatment monitoring of cancer by enabling the high-throughput, continuous-flow ternary separation of single tumor cells, tumor cell clusters, and white blood cells (WBCs) from clinical pleural or abdominal effusions.


Showing results

120 of 24655

close
4.78404